Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment?

van de Garde, E.M., van Bedaf, L.R., Hurkmans, D.P. and van den Heuvel, M.M.

2020-12-01

Annals of Oncology , Volume 31 - Issue 12 p. 1779- 1780

Additional Metadata
Persistent URL	doi.org/10.1016/j.annonc.2020.09.007, hdl.handle.net/1765/132299
Journal	Annals of Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van de Garde, E.M., van Bedaf, L.R., Hurkmans, D.P., & van den Heuvel, M.M. (2020). Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment?. Annals of Oncology, 31(12), 1779–1780. doi:10.1016/j.annonc.2020.09.007

Publication